Fischer Medical Ventures Ltd Share Price Target 2026, 2030, 2035 | Updated Aug 2026
Fischer Medical Ventures Ltd share price today: ₹36.90 | Next market-day median forecast: ₹31.37 (2026-08-31) | 10–90% range: ₹31.37–₹31.37 | Forecast confidence: 52.1% | Chance of upside: 0.0% | Intrinsic value: ₹19.86 | 2027 target: ₹46.56 | 2036 target: ₹59.53
The next market-day median forecast for Fischer Medical Ventures Ltd (2026-08-31) is ₹31.37 which is 14.99% lower than today’s share price of ₹36.90 with a 10–90% range of ₹31.37–₹31.37. The estimate uses available price history, volatility, trend behaviour and intrinsic value gap.
Interactive Share Price Forecast
Choose tomorrow, day after, weekly, monthly or custom trading-day horizons and adjust assumptions to view possible price ranges.
Scenario controls
Uses trading-day intervals for short-term and long-term forecast views.
1 = next market day, 2 = day after, 21 ≈ one trading month.
Scenario adjusts assumptions for cautious, normal or optimistic market conditions.
Wider bands show more uncertainty; narrower bands show central outcomes.
Higher volatility widens the forecast range.
Higher influence gives more weight to intrinsic value in the forecast.
Target date--
Median forecast--
Expected return--
Selected range--
Chance of upside--
Confidence--
Horizon
Target date
Median forecast
Range
Return
Chance of upside
Forecast guide: Explore possible future price ranges using available price history, intrinsic value trend, volatility and valuation gap. Estimates update as fresh market and valuation data become available.
Fischer Medical Ventures Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹19.86 vs CMP ₹36.90 (-46.2%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▼ Bearish
Price/EMA: 0.402 · EMA(252): ₹91.71
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
347.6% annualized
Risk: High · Recent trend: Falling (recent < historical)
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Random walk
Hurst exponent: 0.455
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-14.6%5Y+4.9%10Y
Historical drift: -124.1% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.47x
Upside -46.2% vs downside 97.3% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-85.8%
No margin
Forecast ConfidenceiShows how strongly the forecast is supported by available data, recent forecast behaviour and volatility. Higher confidence means the estimate has better historical support and lower uncertainty.
Moderate (52.1%)
Chance of upside: 0.0% · Avg forecast error: 16.99% · 590 data points
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹1.00
(97.3% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹33.20
₹45.70
CMP: ₹36.9030% into range19.3% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows a possible timeline for the stock price to move closer to its intrinsic value. Milestones show estimated prices at 25%, 50%, 75% and 100% convergence. For overvalued stocks, convergence may indicate downside toward intrinsic value.
Target: ₹19.86 in ~5.0 years (2031)
Now ₹3725% ₹3350% ₹2875% ₹24Target ₹20
Gap: 46.2% downward · Assumed convergence period: 5.0 years
What this means: Fischer Medical Ventures Ltd appears overvalued by 46.2% relative to intrinsic value. The stock is currently in a bearish regime (price below EMA). Volatility is high (347.6% annualized), implying wider price swings and higher risk.
Fischer Medical Ventures Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
46.56
+26.2%
+26.2%
Month
Projected Price (₹)
Jan
30.41
Feb
36.74
Mar
36.30
Apr
31.72
May
42.96
Jun
38.26
Jul
39.37
Aug
37.33
Sep
35.64
Oct
38.37
Nov
40.03
Dec
46.56
2028
27.00
-26.8%
-14.5%
Month
Projected Price (₹)
Jan
52.71
Feb
46.55
Mar
47.55
Apr
52.18
May
55.45
Jun
52.00
Jul
47.50
Aug
43.30
Sep
42.37
Oct
40.54
Nov
30.53
Dec
27.00
2029
31.43
-14.8%
-5.2%
Month
Projected Price (₹)
Jan
26.75
Feb
32.42
Mar
33.19
Apr
39.25
May
34.95
Jun
39.32
Jul
34.81
Aug
33.26
Sep
33.92
Oct
26.34
Nov
32.04
Dec
31.43
2030
19.40
-47.4%
-14.8%
Month
Projected Price (₹)
Jan
35.62
Feb
36.05
Mar
30.93
Apr
34.26
May
28.10
Jun
28.00
Jul
24.30
Aug
20.44
Sep
18.85
Oct
18.28
Nov
19.75
Dec
19.40
2031
16.77
-54.6%
-14.6%
Month
Projected Price (₹)
Jan
18.58
Feb
17.59
Mar
16.54
Apr
16.18
May
15.73
Jun
16.35
Jul
16.23
Aug
17.23
Sep
16.29
Oct
16.47
Nov
15.98
Dec
16.77
2032
19.62
-46.8%
-10.0%
Month
Projected Price (₹)
Jan
16.05
Feb
15.63
Mar
16.18
Apr
16.33
May
16.50
Jun
17.07
Jul
15.74
Aug
15.35
Sep
15.82
Oct
18.14
Nov
19.30
Dec
19.62
2033
18.29
-50.4%
-9.5%
Month
Projected Price (₹)
Jan
20.25
Feb
19.57
Mar
18.37
Apr
19.48
May
20.26
Jun
20.33
Jul
18.72
Aug
19.50
Sep
20.81
Oct
20.03
Nov
19.46
Dec
18.29
2034
20.01
-45.8%
-7.4%
Month
Projected Price (₹)
Jan
19.16
Feb
20.11
Mar
21.08
Apr
20.69
May
20.30
Jun
19.03
Jul
19.33
Aug
18.88
Sep
20.00
Oct
22.21
Nov
20.12
Dec
20.01
2035
39.02
+5.7%
+0.6%
Month
Projected Price (₹)
Jan
20.54
Feb
21.58
Mar
21.96
Apr
20.35
May
21.57
Jun
19.61
Jul
22.72
Aug
24.69
Sep
31.36
Oct
34.14
Nov
37.36
Dec
39.02
2036
59.53
+61.3%
+4.9%
Month
Projected Price (₹)
Jan
36.19
Feb
35.74
Mar
36.69
Apr
36.45
May
36.35
Jun
36.22
Jul
34.31
Aug
40.32
Sep
46.68
Oct
49.68
Nov
60.54
Dec
59.53
Fischer Medical Ventures Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
11.33%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
57.1%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹19.97
PredictionsiTotal number of daily forecasts available for this stock. More observations improve the reliability of accuracy metrics and trend comparison.
Will Fischer Medical Ventures Ltd share price increase on the next market day?
Fischer Medical Ventures Ltd median forecast is ₹31.37 on 2026-08-31, which is 14.99% lower than today’s price of ₹36.90. The 10-90% forecast range is ₹31.37 to ₹31.37. Forecast confidence is 52.1%, with probability-up estimate of 0.0%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.
What is the intrinsic value of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd intrinsic value is ₹19.86, which is 46.18% below the current price of ₹36.90. This suggests the stock is currently overvalued.
What is the share price target of Fischer Medical Ventures Ltd in 2027?
Fischer Medical Ventures Ltd share price target for 2027 is projected to reach ₹46.56 by year-end (range: ₹30.41 to ₹46.56), representing a 26.18% increase from the current price of ₹36.90.
What is the share price target of Fischer Medical Ventures Ltd in 2028?
Fischer Medical Ventures Ltd share price target for 2028 is projected to reach ₹27.00 by year-end (range: ₹27.00 to ₹55.45), representing a -26.83% decrease from the current price of ₹36.90.
What is the share price target of Fischer Medical Ventures Ltd in 2029?
Fischer Medical Ventures Ltd share price target for 2029 is projected to reach ₹31.43 by year-end (range: ₹26.34 to ₹39.32), representing a -14.82% decrease from the current price of ₹36.90.
Should I buy Fischer Medical Ventures Ltd stock now?
Based on current analysis, Fischer Medical Ventures Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹19.86 vs CMP ₹36.90. Use this as a research input and match it with your risk profile, investment horizon and portfolio plan.
What is the fundamental floor price for Fischer Medical Ventures Ltd?
The fundamental floor price for Fischer Medical Ventures Ltd is ₹1.00, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Fischer Medical Ventures Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Fischer Medical Ventures Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The log returns are calculated for each consecutive pair of stock prices between the start date (December 11, 2024) and the end date (August 27, 2026).
590 valid data points from the historical price data in the period from December 11, 2024 to August 27, 2026 have been used for the calculations.
Step 2: Calculate the Exponential Moving Average (EMA)
The EMA is a weighted average of past prices that gives more importance to recent prices. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Fischer Medical Ventures Ltd
The next market-day price forecast uses price trend, volatility, valuation gap and regime adjustment. The displayed value is the median estimate, supported by a 10–90% uncertainty range.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Fischer Medical Ventures Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are informational estimates based on available data and assumptions. Past performance does not guarantee future results. Investors should consider risk profile, investment horizon, portfolio allocation and market risks before acting on any research output. Please read all relevant documents and terms carefully before investing.